TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $97.00 | Market Perform | BMO Capital Markets |
| 10/9/2024 | $97.00 | Buy | TD Cowen |
| 9/5/2024 | $91.00 | Overweight | Barclays |
| 1/8/2024 | $80.00 | Neutral → Buy | Goldman |
| 11/17/2023 | $71.00 | Overweight | Barclays |
| 10/5/2023 | $71.00 | Hold | Deutsche Bank |
| 9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
| 1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
3 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
8-K - METLIFE INC (0001099219) (Filer)
144 - METLIFE INC (0001099219) (Subject)
144 - METLIFE INC (0001099219) (Subject)
BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00
TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00
Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00
My Leave Navigator Supports Individuals Planning Time Away from Work Due to a Planned or Unexpected Life Event MetLife, Inc. (NYSE:MET) has been named as a 2025 CIO 100 Award Winner by Foundry CIO for My Leave Navigator. For almost 30 years, the CIO 100 Awards have recognized innovative organizations that exemplify the highest level of strategic and operational excellence in IT. "Receiving the CIO 100 Award for My Leave Navigator is a testament to our relentless pursuit of innovation that delivers real value for our customers," said Bill Pappas, MetLife's Head of Global Technology and Operations. My Leave Navigator is a part of MetLife's MyBenefits digital experience that support employe
AM Best has assigned a Long-Term Issue Credit Rating of "bbb+" (Good) to the newly issued $1 billion, 6.35% subordinated notes, due March 15, 2055, issued by MetLife, Inc. (MetLife) (headquartered in New York, NY) (NYSE:MET). The outlook assigned to this Credit Rating (rating) is stable. All other ratings of MetLife and its subsidiaries remain unchanged. MetLife's proforma adjusted financial leverage and the historical interest coverage are in line with its current ratings, and its holding company liquidity is strong. This press release relates to Credit Ratings that have been published on AM Best's website. For all rating information relating to the release and pertinent disclosures, inc
MetLife Xcelerator evolves and transforms into a business unit to transform embedded insurance in the region. Driving insurance inclusion through disruptive technology, strategic partnerships, and a fully digital access model as part of MetLife's New Frontier strategy. MetLife, a global leader in insurance solutions, announces the creation of a new regional business unit in Latin America by the name of MetLife Xcelerator, marking a significant milestone in the evolution of the MetLife Xcelerator platform and execution of the company's New Frontier strategy. Designed to lead the transformation of embedded insurance and democratize access to financial protection, the MetLife Xcelerator p
MetLife, Inc. (NYSE:MET) today announced that it has confirmed its previously announced declaration of the first quarter 2025 dividend of $0.35516415 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will set an ex-dividend date for the Series A preferred stock. The dividend will be payable March 17, 2025, to shareholders of record as of Feb. 28, 2025, due to the record date occurring on Sunday, March 2, 2025. About MetLife MetLife,
Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of wh
MetLife, Inc. (NYSE:MET) today announced its full year and fourth quarter 2024 results. Full Year Results Summary Net income of $4.2 billion, compared to net income of $1.4 billion for the full year 2023. Net income of $5.94 per share, up 228 percent from the prior year. Adjusted earnings of $5.8 billion, compared to adjusted earnings of $5.5 billion for the full year 2023. Adjusted earnings of $8.15 per share, up 12 percent from the prior year. Adjusted earnings, excluding total notable items, of $5.8 billion, compared to $5.6 billion for the full year 2023. On a per share basis, adjusted earnings, excluding total notable items, of $8.11, up 11 percent from $7.33 for the full ye
Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh
Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such